236 related articles for article (PubMed ID: 34956202)
1. Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Mitchell J; Kannourakis G
Front Immunol; 2021; 12():773598. PubMed ID: 34956202
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions.
West JA; Olsen SL; Mitchell JM; Priddle RE; Luke JM; Akefeldt SO; Henter JI; Turville C; Kannourakis G
PLoS One; 2014; 9(10):e109586. PubMed ID: 25343480
[TBL] [Abstract][Full Text] [Related]
3. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
[TBL] [Abstract][Full Text] [Related]
4. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
da Costa CE; Egeler RM; Hoogeboom M; Szuhai K; Forsyth RG; Niesters M; de Krijger RR; Tazi A; Hogendoorn PC; Annels NE
J Pathol; 2007 Jun; 212(2):188-97. PubMed ID: 17447723
[TBL] [Abstract][Full Text] [Related]
5. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
[TBL] [Abstract][Full Text] [Related]
6. Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis.
Mitchell J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Sci Rep; 2018 Nov; 8(1):16506. PubMed ID: 30405183
[TBL] [Abstract][Full Text] [Related]
7. Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.
Peters TL; McClain KL; Allen CE
Mol Ther; 2011 Aug; 19(8):1433-9. PubMed ID: 21654633
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
[TBL] [Abstract][Full Text] [Related]
9. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions.
Egeler RM; Favara BE; Laman JD; Claassen E
Eur J Cancer; 2000 Oct; 36(16):2105-10. PubMed ID: 11044648
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow involvement of Langerhans cell histiocytosis: immunohistochemical evaluation of bone marrow for CD1a, Langerin, and S100 expression.
Kim HK; Park CJ; Jang S; Cho YU; Park SH; Koh KN; Im HJ; Seo JJ
Histopathology; 2014 Dec; 65(6):742-8. PubMed ID: 25138018
[TBL] [Abstract][Full Text] [Related]
11. Apparent Lack of
Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
Front Immunol; 2019; 10():3045. PubMed ID: 31998317
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.
Sholl LM; Hornick JL; Pinkus JL; Pinkus GS; Padera RF
Am J Surg Pathol; 2007 Jun; 31(6):947-52. PubMed ID: 17527085
[TBL] [Abstract][Full Text] [Related]
13. CD207
Carrera Silva EA; Nowak W; Tessone L; Olexen CM; Ortiz Wilczyñski JM; Estecho IG; Elena G; Errasti AE; Rosso DA
Blood; 2017 Oct; 130(17):1898-1902. PubMed ID: 28847997
[TBL] [Abstract][Full Text] [Related]
14. [The expression of S-100 protein, CD1a, CD83 and Ki-67 in oral Langerhans cell histiocytosis].
Zhao Y; Zheng Y; Zhang L; Yao T; Wu L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Dec; 29(6):604-9. PubMed ID: 22332572
[TBL] [Abstract][Full Text] [Related]
15. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
Berres ML; Merad M; Allen CE
Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
[TBL] [Abstract][Full Text] [Related]
16. DMC1: a monoclonal antibody produced from histiocytosis X cells which reacts with the native CD1a molecule of human epidermal Langerhans cells.
Dezutter-Dambuyant C; Schmitt D; Staquet MJ; Gaucherand M; Cambazard F; Thivolet J
Hybridoma; 1989 Apr; 8(2):199-208. PubMed ID: 2469637
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.
Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E
J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981
[TBL] [Abstract][Full Text] [Related]
18. Telomere length shortening in Langerhans cell histiocytosis.
Bechan GI; Meeker AK; De Marzo AM; Racke F; Jaffe R; Sugar E; Arceci RJ
Br J Haematol; 2008 Feb; 140(4):420-8. PubMed ID: 18162125
[TBL] [Abstract][Full Text] [Related]
19. CD1a Reactivity in Non-neoplastic Adenohypophysis.
Pisapia DJ; Rosenblum MK; Lavi E
Am J Surg Pathol; 2016 Jun; 40(6):812-7. PubMed ID: 26999501
[TBL] [Abstract][Full Text] [Related]
20. Foxp3
Mitchell J; Kelly J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Clin Immunol; 2020 Jun; 215():108418. PubMed ID: 32283322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
